✦ LIBER ✦

Dose-escalation of human anti-interferon-α receptor monoclonal antibody MEDI-546 in subjects with systemic sclerosis: a phase 1, multicenter, open label study

✍ Scribed by Goldberg, Avram; Geppert, Thomas; Schiopu, Elena; Frech, Tracy; Hsu, Vivien; Simms, Robert W; Peng, Stanford L; Yao, Yihong; Elgeioushi, Nairouz; Chang, Linda; Wang, Bing; Yoo, Stephen

Book ID: 125405562
Publisher: BioMed Central
Year: 2014
Tongue: English
Weight: 602 KB
Volume: 16
Category: Article
ISSN: 1478-6354
DOI: 10.1186/ar4492

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase 1, open-label, dose-escalation s

A phase 1, open-label, dose-escalation study of BIIB022 (anti-IGF-1R monoclonal antibody) in subjects with relapsed or refractory solid tumors

✍ von Mehren, Margaret; Britten, Carolyn D.; Pieslor, Peter; Saville, Wayne; Vasso 📂 Article 📅 2014 🏛 Springer US 🌐 English ⚖ 229 KB

704 A Phase 1 Open-Label, Single-Dose, D

704 A Phase 1 Open-Label, Single-Dose, Dose-Escalation Study of Mdx-1100, a High-Affinity, Neutralizing, Fully Human Igg1κ Anti-CXCL10 (Ip10) Monoclonal Antibody, in Ulcerative Colitis

✍ Robert Hardi; Lloyd Mayer; Stephan R. Targan; Michael Yellin; Pina M. Cardarelli 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 185 KB

647 POSTER A phase I dose-escalation stu

647 POSTER A phase I dose-escalation study of weekly IMC-1121B, a fully human anti-vascular endothelial growth factor receptor 2 (VEGFR2) IgG1 monoclonal antibody (Mab), in patients (pts) with advanced cancer

✍ R. Cohen; D. Camidge; S. Diab; L. Gore; L. Chow; C. O'Bryant; E. Temmer; F. Fox; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 59 KB